Dimension Therapeutics, Inc.
CIK 1592288 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Dimension Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 17, 2017 | 15-12B | 0001193125-17-346942 |
| Nov 13, 2017 | EFFECT | 9999999995-17-002956 |
| Nov 9, 2017 | 4 | 0000315066-17-002872 |
| Nov 7, 2017 | 4 | 0001209191-17-059623 |
| Nov 7, 2017 | 8-K | 0001193125-17-335270 |
| Nov 7, 2017 | 4 | 0001209191-17-059626 |
| Nov 7, 2017 | 4 | 0001209191-17-059631 |
| Nov 7, 2017 | 4 | 0001209191-17-059630 |
| Nov 7, 2017 | 4 | 0001209191-17-059624 |
| Nov 7, 2017 | 25-NSE | 0001354457-17-000225 |
| Nov 7, 2017 | SC TO-T/A | 0001193125-17-335103 |
| Nov 7, 2017 | 4 | 0001209191-17-059632 |
| Nov 7, 2017 | SC 14D9/A | 0001193125-17-335201 |
| Nov 7, 2017 | POS AM | 0001193125-17-335133 |
| Nov 7, 2017 | 4 | 0001209191-17-059634 |
| Nov 7, 2017 | S-8 POS | 0001193125-17-335142 |
| Nov 7, 2017 | 4 | 0001209191-17-059625 |
| Nov 7, 2017 | S-8 POS | 0001193125-17-335135 |
| Nov 7, 2017 | 4 | 0001209191-17-059627 |
| Nov 7, 2017 | 4 | 0001209191-17-059629 |
| Nov 7, 2017 | S-8 POS | 0001193125-17-335141 |
| Nov 6, 2017 | 10-Q | 0001564590-17-021788 |
| Oct 27, 2017 | SC 14D9/A | 0001193125-17-323238 |
| Oct 26, 2017 | SC TO-T/A | 0001193125-17-320293 |
| Oct 26, 2017 | SC 14D9/A | 0001193125-17-320301 |